Inventor
SAM JOHANNES
CH7 patents
Patents
7 patentsUS11608376B2Mar 21, 2023
Tumor-targeted agonistic CD28 antigen binding molecules
HOFFMANN LA ROCHE14 citations82
US11718680B2Aug 8, 2023
Combination therapy of anti-CD20/anti-CD3 bispecific antibodies and 4-1BB (CD137) agonists
HOFFMANN LA ROCHE5 citations73
US11192957B2Dec 7, 2021
Antibodies binding to HLA-A2/WT1
HOFFMANN LA ROCHE2 citations72
US10596257B2Mar 24, 2020
Methods of treating CEA-positive cancers using PD-1 axis binding antagonists and anti-CEA/anti-CD3 bispecific antibodies
HOFFMANN LA ROCHE5 citations68
US12281153B2Apr 22, 2025
Combination therapy with targeted 4-1BB (CD137) agonists
HOFFMANN LA ROCHE0 citations62
US12098213B2Sep 24, 2024
Antibodies binding to HLA-A2/WT1
HOFFMANN LA ROCHE0 citations61
US11780919B2Oct 10, 2023
Bispecific antigen binding molecules targeting OX40 and FAP
HOFFMANN LA ROCHE1 citations56